| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.992 | 0 | 0.992 | NOS3 expression enhancer | 0.931 0.001 CID_65036 0.703 0.003 CID_154699921 | ||
| 0.966 | 0.004 | 0.988 | Apoptosis agonist | 0.988 0.002 CID_65036 0.839 0.012 CID_154699921 | CID_65036 | |
| 0.796 | 0.004 | 0.996 | Hypoglycemic | 0.996 0.001 CID_65036 0.305 0.051 CID_154699921 | CID_65036 | |
| 0.791 | 0.001 | 0.791 | ErbB-3 antagonist | 0.218 0.007 CID_65036 0.168 0.014 CID_154699921 | ||
| 0.7 | 0.003 | 0.7 | Lipid peroxidase inhibitor | 0.282 0.021 CID_65036 0.26 0.025 CID_154699921 | ||
| 0.695 | 0.004 | 0.867 | Hepatoprotectant | 0.867 0.002 CID_65036 0.396 0.014 CID_154699921 | CID_65036 | |
| 0.641 | 0.009 | 0.985 | Antioxidant | 0.985 0.001 CID_65036 0.326 0.053 CID_154699921 | CID_65036 | |
| 0.621 | 0.005 | 0.621 | GABA C receptor rho-3 antagonist | 0.485 0.03 CID_65036 | ||
| 0.607 | 0.018 | 0.607 | Cholesterol antagonist | 0.301 0.091 CID_65036 | ||
| 0.595 | 0.007 | 0.595 | Antimitotic | |||
| 0.628 | 0.046 | 0.628 | Antiinflammatory | 0.578 0.06 CID_154699921 | ||
| 0.575 | 0.003 | 0.821 | TRPA1 agonist | 0.821 0.002 CID_65036 | CID_65036 | |
| 0.567 | 0.008 | 0.988 | Platelet antagonist | 0.988 0.001 CID_65036 0.522 0.012 CID_154699921 | CID_65036 | |
| 0.56 | 0.002 | 0.998 | Falcipain inhibitor | 0.998 0 CID_65036 0.202 0.014 CID_154699921 | CID_65036 | |
| 0.556 | 0.002 | 0.998 | Falcipain 2 inhibitor | 0.998 0 CID_65036 0.198 0.014 CID_154699921 | CID_65036 | |
| 0.538 | 0.01 | 0.982 | Hypolipemic | 0.982 0.002 CID_65036 | CID_65036 | |
| 0.524 | 0.026 | 0.635 | Antithrombotic | 0.272 0.109 CID_65036 0.635 0.013 CID_154699921 | CID_154699921 | |
| 0.505 | 0.041 | 0.505 | Prostaglandin dehydrogenase inhibitor | |||
| 0.504 | 0.044 | 0.504 | Transcription factor NF kappa B inhibitor | 0.219 0.151 CID_65036 0.467 0.049 CID_154699921 | ||
| 0.462 | 0.004 | 0.462 | Histone deacetylase SIRT1 stimulant | 0.115 0.02 CID_65036 | ||
| 0.462 | 0.004 | 0.462 | Histone deacetylase stimulant | 0.115 0.02 CID_65036 | ||
| 0.438 | 0.012 | 0.438 | Anesthetic general | 0.147 0.116 CID_65036 | ||
| 0.464 | 0.038 | 0.464 | Aldehyde oxidase inhibitor | 0.205 0.102 CID_65036 | ||
| 0.426 | 0.004 | 0.998 | Telomerase inhibitor | 0.998 0 CID_65036 | CID_65036 | |
| 0.44 | 0.06 | 0.588 | Antibacterial | 0.588 0.021 CID_65036 0.579 0.023 CID_154699921 | CID_65036 | |
| 0.376 | 0.005 | 0.376 | Succinate dehydrogenase inhibitor | 0.276 0.015 CID_65036 | ||
| 0.411 | 0.046 | 0.719 | Immunostimulant | 0.285 0.083 CID_65036 0.719 0.007 CID_154699921 | CID_154699921 | |
| 0.392 | 0.028 | 0.392 | Tumour necrosis factor alpha release inhibitor | |||
| 0.372 | 0.032 | 0.372 | Superoxide dismutase inhibitor | 0.213 0.104 CID_65036 0.236 0.084 CID_154699921 | ||
| 0.354 | 0.024 | 0.354 | 5 Hydroxytryptamine uptake stimulant | 0.246 0.084 CID_65036 | ||
| 0.345 | 0.029 | 0.432 | Peroxidase inhibitor | 0.138 0.085 CID_65036 0.432 0.016 CID_154699921 | CID_154699921 | |
| 0.358 | 0.048 | 0.358 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.237 0.082 CID_65036 | ||
| 0.364 | 0.053 | 0.364 | 5 Hydroxytryptamine release stimulant | 0.167 0.156 CID_65036 | ||
| 0.316 | 0.006 | 0.316 | Adenylate kinase inhibitor | 0.219 0.013 CID_65036 0.176 0.019 CID_154699921 | ||
| 0.343 | 0.035 | 0.343 | Transcription factor STAT3 inhibitor | |||
| 0.324 | 0.02 | 0.384 | Thrombolytic | 0.384 0.013 CID_154699921 | CID_154699921 | |
| 0.358 | 0.057 | 0.358 | Caspase 3 stimulant | 0.312 0.073 CID_154699921 | ||
| 0.311 | 0.015 | 0.311 | Alpha-N-acetylglucosaminidase inhibitor | 0.166 0.047 CID_65036 | ||
| 0.298 | 0.009 | 0.298 | GABA C receptor agonist | 0.152 0.033 CID_65036 | ||
| 0.342 | 0.059 | 0.401 | Apoptosis antagonist | 0.401 0.038 CID_154699921 | CID_154699921 | |
| 0.294 | 0.014 | 0.294 | Acetylcholinesterase inhibitor | |||
| 0.284 | 0.005 | 0.284 | GABA C receptor antagonist | 0.179 0.018 CID_65036 | ||
| 0.288 | 0.009 | 0.288 | Ferrochelatase inhibitor | 0.141 0.042 CID_65036 | ||
| 0.393 | 0.115 | 0.393 | Caspase 9 stimulant | |||
| 0.367 | 0.092 | 0.367 | Histamine release inhibitor | 0.306 0.121 CID_154699921 | ||
| 0.32 | 0.045 | 0.32 | Transcription factor STAT inhibitor | |||
| 0.275 | 0.004 | 0.541 | TRPA1 antagonist | 0.541 0.003 CID_65036 | CID_65036 | |
| 0.311 | 0.043 | 0.311 | Amyloid beta aggregation inhibitor | |||
| 0.316 | 0.049 | 0.358 | Insulysin inhibitor | 0.218 0.132 CID_65036 0.358 0.031 CID_154699921 | CID_154699921 | |
| 0.275 | 0.012 | 0.275 | UDP-glucose 4-epimerase inhibitor | 0.115 0.047 CID_65036 | ||
| 0.267 | 0.009 | 0.267 | GABA C receptor rho-2 antagonist | 0.175 0.047 CID_65036 | ||
| 0.264 | 0.013 | 0.264 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.321 | 0.072 | 0.321 | Calcium channel activator | |||
| 0.254 | 0.008 | 0.273 | Microtubule formation inhibitor | 0.273 0.004 CID_65036 0.126 0.054 CID_154699921 | CID_65036 | |
| 0.254 | 0.009 | 0.254 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.125 0.036 CID_65036 0.13 0.034 CID_154699921 | ||
| 0.269 | 0.024 | 0.269 | Cholinergic | |||
| 0.262 | 0.028 | 0.285 | Insulin sensitizer | 0.182 0.093 CID_65036 0.285 0.019 CID_154699921 | CID_154699921 | |
| 0.269 | 0.039 | 0.269 | DNA methyltransferase I inhibitor | 0.141 0.114 CID_154699921 | ||
| 0.274 | 0.048 | 0.274 | Tyrosine 3 hydroxylase inhibitor | 0.205 0.128 CID_65036 | ||
| 0.362 | 0.137 | 0.362 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.249 | 0.025 | 0.478 | Phospholipase C inhibitor | 0.167 0.076 CID_65036 0.478 0.007 CID_154699921 | CID_154699921 | |
| 0.231 | 0.008 | 0.27 | Glutamate dehydrogenase inhibitor | 0.139 0.018 CID_65036 0.27 0.006 CID_154699921 | CID_154699921 | |
| 0.228 | 0.008 | 0.228 | Triose-phosphate isomerase inhibitor | 0.146 0.021 CID_65036 | ||
| 0.26 | 0.043 | 0.26 | DNA methylase inhibitor | 0.17 0.1 CID_154699921 | ||
| 0.268 | 0.056 | 0.268 | 5 Hydroxytryptamine 1E antagonist | 0.182 0.152 CID_65036 | ||
| 0.24 | 0.029 | 0.452 | Thiol protease inhibitor | 0.452 0.011 CID_65036 0.361 0.015 CID_154699921 | CID_65036 | |
| 0.27 | 0.061 | 0.27 | Free radical scavenger | 0.209 0.091 CID_154699921 | ||
| 0.213 | 0.006 | 0.455 | Glutamate decarboxylase inhibitor | 0.128 0.018 CID_65036 0.455 0.003 CID_154699921 | CID_154699921 | |
| 0.211 | 0.006 | 0.298 | Ornithine carbamoyltransferase inhibitor | 0.093 0.018 CID_65036 0.298 0.004 CID_154699921 | CID_154699921 | |
| 0.21 | 0.007 | 0.21 | GABA C receptor rho-1 antagonist | 0.122 0.039 CID_65036 | ||
| 0.289 | 0.088 | 0.638 | Immunomodulator | 0.638 0.008 CID_154699921 | CID_154699921 | |
| 0.21 | 0.01 | 0.21 | Phosphofructokinase-1 inhibitor | 0.136 0.021 CID_65036 0.059 0.058 CID_154699921 | ||
| 0.209 | 0.011 | 0.209 | Porphobilinogen synthase inhibitor | 0.108 0.033 CID_65036 | ||
| 0.232 | 0.034 | 0.232 | Cytidine deaminase inhibitor | |||
| 0.204 | 0.008 | 0.312 | Thioredoxin inhibitor | 0.312 0.003 CID_65036 | CID_65036 | |
| 0.225 | 0.031 | 0.225 | 5 Hydroxytryptamine 3E antagonist | 0.191 0.08 CID_65036 | ||
| 0.313 | 0.123 | 0.313 | 15-Lipoxygenase inhibitor | |||
| 0.202 | 0.013 | 0.202 | Adenylate cyclase stimulant | 0.16 0.048 CID_65036 | ||
| 0.193 | 0.008 | 0.193 | CYP2A6 inhibitor | |||
| 0.19 | 0.006 | 0.19 | Acyl-CoA dehydrogenase inhibitor | 0.103 0.015 CID_65036 | ||
| 0.208 | 0.026 | 0.208 | Arachidonic acid antagonist | 0.164 0.072 CID_65036 | ||
| 0.195 | 0.02 | 0.195 | Cyclooxygenase 3 inhibitor | 0.124 0.073 CID_154699921 | ||
| 0.188 | 0.016 | 0.243 | Mucolytic | 0.099 0.079 CID_65036 0.243 0.007 CID_154699921 | CID_154699921 | |
| 0.205 | 0.034 | 0.451 | Cytokine production inhibitor | 0.451 0.005 CID_65036 | CID_65036 | |
| 0.172 | 0.006 | 0.172 | Bruton tyrosine kinase inhibitor | |||
| 0.173 | 0.007 | 0.173 | Biliverdin reductase inhibitor | 0.086 0.023 CID_65036 | ||
| 0.176 | 0.012 | 0.176 | Electrolyte absorption antagonist | 0.119 0.037 CID_65036 | ||
| 0.194 | 0.029 | 0.194 | Aldehyde dehydrogenase inhibitor | |||
| 0.176 | 0.015 | 0.176 | Creatine kinase inhibitor | 0.112 0.047 CID_65036 | ||
| 0.242 | 0.089 | 0.242 | Gastrin inhibitor | |||
| 0.16 | 0.009 | 0.294 | Ornithine decarboxylase inhibitor | 0.294 0.003 CID_65036 0.126 0.022 CID_154699921 | CID_65036 | |
| 0.166 | 0.017 | 0.166 | Ca2+-transporting ATPase inhibitor | 0.143 0.062 CID_65036 | ||
| 0.17 | 0.023 | 0.175 | Vanilloid 1 agonist | 0.114 0.104 CID_65036 0.175 0.021 CID_154699921 | CID_154699921 | |
| 0.172 | 0.028 | 0.24 | Expectorant | 0.24 0.014 CID_154699921 | CID_154699921 | |
| 0.149 | 0.012 | 0.149 | Phenylalanine 4-hydroxylase inhibitor | 0.08 0.038 CID_65036 0.064 0.052 CID_154699921 | ||
| 0.156 | 0.019 | 0.156 | ErbB-4 antagonist | |||
| 0.156 | 0.022 | 0.156 | Epidermal growth factor antagonist | |||
| 0.212 | 0.083 | 0.212 | RNA-directed DNA polymerase inhibitor | |||
| 0.179 | 0.052 | 0.179 | Melanin inhibitor | |||
| 0.137 | 0.015 | 0.462 | Glutathione S-transferase inhibitor | 0.083 0.057 CID_65036 0.462 0.002 CID_154699921 | CID_154699921 | |
| 0.209 | 0.088 | 0.296 | Peptidyltransferase inhibitor | 0.296 0.026 CID_154699921 | CID_154699921 | |
| 0.156 | 0.035 | 0.304 | Aminopeptidase B inhibitor | 0.097 0.067 CID_65036 0.304 0.008 CID_154699921 | CID_154699921 | |
| 0.17 | 0.049 | 0.17 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.203 | 0.083 | 0.203 | Nitric-oxide synthase stimulant | |||
| 0.172 | 0.054 | 0.172 | Protein kinase stimulant | |||
| 0.217 | 0.099 | 0.217 | DNA synthesis inhibitor | |||
| 0.127 | 0.012 | 0.127 | Aminopeptidase microsomal inhibitor | 0.111 0.015 CID_154699921 | ||
| 0.234 | 0.119 | 0.234 | 12-Lipoxygenase inhibitor | |||
| 0.139 | 0.024 | 0.139 | Anabolic | 0.101 0.061 CID_65036 | ||
| 0.159 | 0.046 | 0.219 | Toll-Like receptor 2 antagonist | 0.219 0.016 CID_154699921 | CID_154699921 | |
| 0.116 | 0.005 | 0.116 | Exportin-1 inhibitor | 0.083 0.022 CID_65036 | ||
| 0.133 | 0.023 | 0.332 | Histidine decarboxylase inhibitor | 0.332 0.005 CID_154699921 | CID_154699921 | |
| 0.125 | 0.015 | 0.125 | Carbamoyl phosphate synthetase inhibitor | 0.079 0.029 CID_65036 | ||
| 0.138 | 0.029 | 0.169 | Catalase inhibitor | 0.169 0.022 CID_154699921 | CID_154699921 | |
| 0.137 | 0.028 | 0.137 | Prolactin inhibitor | |||
| 0.161 | 0.055 | 0.22 | Cell wall synthesis inhibitor | 0.22 0.023 CID_154699921 | CID_154699921 | |
| 0.11 | 0.005 | 0.125 | Factor XIIIa inhibitor | 0.125 0.004 CID_154699921 | CID_154699921 | |
| 0.197 | 0.092 | 0.197 | ErbB-1 antagonist | |||
| 0.235 | 0.134 | 0.235 | Angiogenesis inhibitor | |||
| 0.104 | 0.004 | 0.104 | Ryanodine receptor antagonist | 0.062 0.032 CID_65036 | ||
| 0.131 | 0.032 | 0.135 | Nitric-oxide synthase inhibitor | 0.135 0.03 CID_154699921 | CID_154699921 | |
| 0.111 | 0.011 | 0.111 | Aminopeptidase N inhibitor | 0.093 0.014 CID_154699921 | ||
| 0.148 | 0.049 | 0.148 | Heat shock protein 70 antagonist | |||
| 0.188 | 0.088 | 0.188 | Histone acetyltransferase inhibitor | |||
| 0.146 | 0.047 | 0.146 | Adenylate cyclase inhibitor | |||
| 0.117 | 0.018 | 0.117 | GABA aminotransferase inhibitor | 0.068 0.065 CID_65036 | ||
| 0.122 | 0.024 | 0.122 | Inducible nitric-oxide synthase inhibitor | 0.112 0.028 CID_154699921 | ||
| 0.113 | 0.015 | 0.113 | Glycine receptor agonist | 0.071 0.052 CID_65036 | ||
| 0.158 | 0.06 | 0.158 | Amylase inhibitor | |||
| 0.145 | 0.049 | 0.145 | Alkylator | 0.101 0.087 CID_154699921 | ||
| 0.269 | 0.173 | 0.269 | Transcription factor inhibitor | |||
| 0.122 | 0.028 | 0.122 | NADH dehydrogenase inhibitor | 0.084 0.066 CID_65036 | ||
| 0.239 | 0.145 | 0.239 | Vasodilator, coronary | |||
| 0.107 | 0.014 | 0.107 | Bcl2 antagonist | |||
| 0.173 | 0.08 | 0.281 | Nitric oxide antagonist | 0.281 0.044 CID_154699921 | CID_154699921 | |
| 0.108 | 0.016 | 0.108 | Alcohol oxidase inhibitor | |||
| 0.139 | 0.049 | 0.139 | Beta amyloid protein antagonist | |||
| 0.103 | 0.014 | 0.103 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.059 0.036 CID_65036 | ||
| 0.135 | 0.047 | 0.135 | Alpha 2b adrenoreceptor antagonist | |||
| 0.114 | 0.026 | 0.114 | Somatostatin 1 agonist | 0.103 0.032 CID_154699921 | ||
| 0.098 | 0.011 | 0.098 | Fatty acid synthase inhibitor | |||
| 0.126 | 0.039 | 0.126 | Gastric antisecretory | |||
| 0.12 | 0.035 | 0.12 | Alcohol dehydrogenase inhibitor | |||
| 0.087 | 0.004 | 0.087 | Dopamine beta hydroxylase inhibitor | 0.054 0.023 CID_65036 | ||
| 0.093 | 0.011 | 0.093 | Fibroblast growth factor 4 antagonist | |||
| 0.154 | 0.072 | 0.154 | Interferon gamma antagonist | |||
| 0.09 | 0.01 | 0.09 | Histone deacetylase 5 inhibitor | |||
| 0.152 | 0.073 | 0.152 | CF transmembrane conductance regulator agonist | |||
| 0.275 | 0.195 | 0.275 | 5 Hydroxytryptamine release inhibitor | |||
| 0.086 | 0.007 | 0.086 | Glucose-6-phosphate isomerase inhibitor | 0.062 0.017 CID_65036 | ||
| 0.082 | 0.005 | 0.123 | Membrane dipeptidase inhibitor | 0.045 0.02 CID_65036 0.123 0.003 CID_154699921 | CID_154699921 | |
| 0.11 | 0.034 | 0.11 | Topoisomerase II alpha inhibitor | |||
| 0.105 | 0.028 | 0.105 | Vanilloid agonist | 0.095 0.039 CID_154699921 | ||
| 0.085 | 0.011 | 0.156 | Epithelial sodium channel blocker | 0.156 0.003 CID_65036 | CID_65036 | |
| 0.129 | 0.056 | 0.129 | Monophenol monooxygenase inhibitor | |||
| 0.125 | 0.052 | 0.125 | Photosensitizer | |||
| 0.146 | 0.073 | 0.146 | Cyclooxygenase inhibitor | |||
| 0.15 | 0.078 | 0.15 | Diuretic | |||
| 0.079 | 0.008 | 0.079 | Adenylate cyclase 1 inhibitor | |||
| 0.15 | 0.08 | 0.419 | Anticoagulant | 0.419 0.015 CID_154699921 | CID_154699921 | |
| 0.092 | 0.022 | 0.092 | MAP kinase kinase 7 inhibitor | |||
| 0.11 | 0.041 | 0.11 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.079 | 0.011 | 0.079 | Dihydroorotate oxidase inhibitor | 0.053 0.043 CID_65036 | ||
| 0.1 | 0.032 | 0.1 | Glycine receptor antagonist | |||
| 0.111 | 0.044 | 0.111 | Uric acid excretion stimulant | |||
| 0.191 | 0.124 | 0.191 | DNA damaging | |||
| 0.081 | 0.014 | 0.081 | Aconitate hydratase inhibitor | 0.047 0.044 CID_65036 | ||
| 0.132 | 0.065 | 0.132 | Antibacterial (Helicobacter pylori) | |||
| 0.089 | 0.023 | 0.089 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.095 | 0.031 | 0.137 | Aminopeptidase I inhibitor | 0.137 0.015 CID_154699921 | CID_154699921 | |
| 0.117 | 0.053 | 0.117 | Acetylcholine release stimulant | |||
| 0.11 | 0.046 | 0.11 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.117 | 0.054 | 0.122 | Nav1.4 sodium channel blocker | 0.122 0.05 CID_154699921 | CID_154699921 | |
| 0.074 | 0.012 | 0.074 | Lysophosphatidic acid 3 receptor antagonist | 0.048 0.039 CID_65036 0.051 0.034 CID_154699921 | ||
| 0.178 | 0.116 | 0.178 | Antiamyloidogenic | |||
| 0.083 | 0.023 | 0.997 | Cathepsin B inhibitor | 0.997 0 CID_65036 0.095 0.018 CID_154699921 | CID_65036 | |
| 0.1 | 0.039 | 0.129 | Transcription factor NF kappa B stimulant | 0.129 0.021 CID_154699921 | CID_154699921 | |
| 0.094 | 0.037 | 0.094 | Na+ K+ transporting ATPase inhibitor | |||
| 0.091 | 0.034 | 0.091 | CC chemokine 5 receptor agonist | |||
| 0.063 | 0.006 | 0.063 | Kainate receptor agonist | 0.044 0.023 CID_65036 | ||
| 0.068 | 0.011 | 0.068 | Histone deacetylase class IIa inhibitor | |||
| 0.14 | 0.085 | 0.14 | Acetylcholine M1 receptor antagonist | |||
| 0.125 | 0.07 | 0.125 | Cathepsin H inhibitor | |||
| 0.191 | 0.137 | 0.191 | Neuropeptide Y2 antagonist | |||
| 0.151 | 0.1 | 0.151 | ATPase inhibitor | |||
| 0.07 | 0.02 | 0.1 | Angiotensin-converting enzyme inhibitor | 0.1 0.009 CID_154699921 | CID_154699921 | |
| 0.113 | 0.064 | 0.113 | Cystathionine beta-synthase inhibitor | |||
| 0.077 | 0.029 | 0.077 | Glutamate (mGluR6) antagonist | |||
| 0.1 | 0.053 | 0.1 | Phosphodiesterase 6D inhibitor | |||
| 0.137 | 0.091 | 0.137 | MAP kinase 3 inhibitor | |||
| 0.082 | 0.037 | 0.082 | Vanilloid 4 agonist | |||
| 0.074 | 0.028 | 0.074 | Argininosuccinate synthase inhibitor | |||
| 0.115 | 0.07 | 0.161 | Proteasome inhibitor | 0.161 0.04 CID_154699921 | CID_154699921 | |
| 0.059 | 0.014 | 0.059 | Retinoid X receptor agonist | |||
| 0.088 | 0.044 | 0.088 | Thioredoxin reductase inhibitor | |||
| 0.154 | 0.11 | 0.154 | Non-steroidal antiinflammatory agent | |||
| 0.059 | 0.015 | 0.059 | Microtubule stabilization | |||
| 0.121 | 0.078 | 0.121 | Cyclooxygenase 2 inhibitor | |||
| 0.054 | 0.012 | 0.054 | Histone deacetylase 11 inhibitor | |||
| 0.054 | 0.012 | 0.054 | Histone deacetylase class IV inhibitor | |||
| 0.106 | 0.066 | 0.106 | DOPA decarboxylase inhibitor | |||
| 0.061 | 0.023 | 0.061 | Immunoglobulin Fc receptor antagonist | |||
| 0.049 | 0.012 | 0.049 | Glutamate (mGluR8) agonist | |||
| 0.164 | 0.129 | 0.164 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.1 | 0.066 | 0.1 | Alpha 2c adrenoreceptor antagonist | |||
| 0.07 | 0.035 | 0.07 | 5 Hydroxytryptamine 3 agonist | |||
| 0.047 | 0.013 | 0.047 | Histone deacetylase 10 inhibitor | |||
| 0.07 | 0.037 | 0.07 | Protease 3C (Human rhinovirus) inhibitor | 0.059 0.054 CID_154699921 | ||
| 0.159 | 0.125 | 0.159 | Neurotrophic factor enhancer | |||
| 0.067 | 0.035 | 0.067 | Transcription factor RelA inhibitor | |||
| 0.075 | 0.043 | 0.075 | Phospholipase D inhibitor | |||
| 0.104 | 0.072 | 0.195 | Chelator | 0.195 0.025 CID_154699921 | CID_154699921 | |
| 0.046 | 0.014 | 0.046 | Histone deacetylase 4 inhibitor | |||
| 0.048 | 0.017 | 0.048 | Heme oxygenase inhibitor | |||
| 0.046 | 0.015 | 0.046 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.041 | 0.011 | 0.041 | Uridine phosphorylase inhibitor | |||
| 0.09 | 0.061 | 0.09 | Glutamate release inhibitor | |||
| 0.045 | 0.016 | 0.045 | Fumarate hydratase inhibitor | |||
| 0.047 | 0.019 | 0.047 | Histone deacetylase 7 inhibitor | |||
| 0.046 | 0.019 | 0.046 | GABA uptake inhibitor | |||
| 0.055 | 0.028 | 0.073 | Antimetabolite | 0.073 0.021 CID_154699921 | CID_154699921 | |
| 0.034 | 0.008 | 0.034 | Glutamate (mGluR1) agonist | |||
| 0.054 | 0.028 | 0.054 | Squalene epoxidase inhibitor | |||
| 0.142 | 0.116 | 0.142 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.044 | 0.02 | 0.044 | Histone deacetylase 9 inhibitor | |||
| 0.031 | 0.007 | 0.031 | Complement factor 1s inhibitor | |||
| 0.085 | 0.062 | 0.085 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.064 | 0.041 | 0.112 | Nitric oxide donor | 0.112 0.005 CID_154699921 | CID_154699921 | |
| 0.104 | 0.082 | 0.104 | Cholesterol synthesis inhibitor | |||
| 0.036 | 0.014 | 0.036 | Histone deacetylase class II inhibitor | |||
| 0.032 | 0.011 | 0.032 | Nicotinic acid receptor 2 antagonist | |||
| 0.03 | 0.01 | 0.03 | Vanilloid 2 agonist | |||
| 0.06 | 0.04 | 0.064 | Cathepsin E inhibitor | 0.064 0.035 CID_154699921 | CID_154699921 | |
| 0.036 | 0.015 | 0.036 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.041 | 0.022 | 0.041 | Retinoid X receptor antagonist | |||
| 0.049 | 0.029 | 0.061 | Thymidylate synthase inhibitor | 0.061 0.016 CID_154699921 | CID_154699921 | |
| 0.026 | 0.007 | 0.026 | Factor XIII inhibitor | 0.02 0.017 CID_65036 | ||
| 0.036 | 0.016 | 0.036 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.043 | 0.025 | 0.043 | Thymidine kinase inhibitor | |||
| 0.037 | 0.019 | 0.037 | Retinoid X alpha receptor antagonist | |||
| 0.054 | 0.036 | 0.054 | Alpha-mannosidase inhibitor | |||
| 0.058 | 0.04 | 0.058 | Botulinum neurotoxin type A inhibitor | |||
| 0.055 | 0.037 | 0.116 | Ribonucleoside-diphosphate reductase inhibitor | 0.116 0.016 CID_154699921 | CID_154699921 | |
| 0.036 | 0.019 | 0.036 | Melatonin receptor 1A agonist | |||
| 0.06 | 0.043 | 0.06 | Alpha 2 adrenoreceptor agonist | |||
| 0.059 | 0.042 | 0.059 | Aromatase inhibitor | |||
| 0.044 | 0.028 | 0.044 | Histamine H2 receptor agonist | |||
| 0.055 | 0.039 | 0.112 | Ribonucleotide reductase inhibitor | 0.112 0.018 CID_154699921 | CID_154699921 | |
| 0.031 | 0.015 | 0.031 | Vasopressin 1A agonist | |||
| 0.044 | 0.028 | 0.044 | Oxytocin agonist | 0.038 0.034 CID_154699921 | ||
| 0.089 | 0.074 | 0.089 | Xanthine oxidase inhibitor | |||
| 0.023 | 0.008 | 0.023 | Alpha 2c adrenoreceptor agonist | |||
| 0.039 | 0.024 | 0.039 | Vanilloid 3 antagonist | |||
| 0.023 | 0.009 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.044 | 0.03 | 0.044 | Dihydrofolate reductase inhibitor | |||
| 0.025 | 0.012 | 0.025 | Glutamate (mGluR1a) agonist | |||
| 0.125 | 0.111 | 0.125 | Neuropeptide Y1 antagonist | |||
| 0.045 | 0.031 | 0.045 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.066 | 0.052 | 0.066 | MDM2 inhibitor | |||
| 0.023 | 0.01 | 0.023 | Neuraminidase (Influenza B) inhibitor | |||
| 0.021 | 0.008 | 0.021 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.029 | 0.016 | 0.029 | Urotensin II agonist | |||
| 0.044 | 0.031 | 0.044 | Geranyltranstransferase inhibitor | |||
| 0.048 | 0.036 | 0.056 | HCV NS3/NS4A protease inhibitor | 0.056 0.024 CID_154699921 | CID_154699921 | |
| 0.039 | 0.027 | 0.039 | Somatostatin 1 antagonist | |||
| 0.09 | 0.078 | 0.09 | Urease inhibitor | |||
| 0.025 | 0.013 | 0.025 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.035 | 0.024 | 0.035 | Retinoid X alpha receptor agonist | |||
| 0.058 | 0.047 | 0.058 | Purinergic P2X1 antagonist | |||
| 0.02 | 0.009 | 0.02 | Carbonic anhydrase VIII inhibitor | |||
| 0.02 | 0.009 | 0.02 | Carbonic anhydrase X inhibitor | |||
| 0.039 | 0.028 | 0.039 | Dihydropteroate synthase inhibitor | |||
| 0.041 | 0.03 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.045 | 0.035 | 0.045 | Adenosine deaminase inhibitor | |||
| 0.108 | 0.099 | 0.108 | NADPH oxidase inhibitor | |||
| 0.023 | 0.014 | 0.023 | Prostaglandin F2 alpha agonist | |||
| 0.048 | 0.039 | 0.048 | Potassium channel (Inward rectifier) activator | |||
| 0.058 | 0.05 | 0.058 | NMDA receptor agonist | |||
| 0.021 | 0.013 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.034 | 0.025 | 0.034 | HMG CoA reductase inhibitor | |||
| 0.028 | 0.019 | 0.028 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.046 | 0.038 | 0.046 | Potassium channel (ATP-sensitive) activator | |||
| 0.026 | 0.019 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.038 | 0.031 | 0.038 | Dopamine D5 agonist | |||
| 0.123 | 0.116 | 0.336 | Growth hormone agonist | 0.336 0.025 CID_154699921 | CID_154699921 | |
| 0.042 | 0.036 | 0.042 | Mannosidase inhibitor | |||
| 0.051 | 0.044 | 0.051 | Carbonic anhydrase VB inhibitor | |||
| 0.025 | 0.018 | 0.025 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.089 | 0.083 | 0.089 | Mediator release inhibitor | |||
| 0.05 | 0.044 | 0.05 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.07 | 0.065 | 0.07 | Keratolytic | |||
| 0.054 | 0.048 | 0.054 | Leukotriene C antagonist | |||
| 0.108 | 0.103 | 0.108 | Alkaline phosphatase inhibitor | |||
| 0.068 | 0.064 | 0.068 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.013 | 0.009 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.115 | 0.111 | 0.115 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.029 | 0.026 | 0.029 | ATP citrate lysase inhibitor | |||
| 0.05 | 0.047 | 0.05 | Glucosylceramidase inhibitor | |||
| 0.018 | 0.015 | 0.018 | Alpha 2b adrenoreceptor agonist | |||
| 0.021 | 0.019 | 0.021 | Isoleucine-tRNA ligase inhibitor | |||
| 0.016 | 0.015 | 0.031 | Aminopeptidase A inhibitor | 0.031 0.006 CID_154699921 | CID_154699921 | |
| 0.036 | 0.035 | 0.036 | 5 Hydroxytryptamine 2B agonist | |||
| 0.024 | 0.023 | 0.032 | Lysine carboxypeptidase inhibitor | 0.032 0.014 CID_154699921 | CID_154699921 | |
| 0.053 | 0.052 | 0.053 | Pregnane X receptor antagonist | |||
| 0.05 | 0.051 | 0.124 | Cathepsin L inhibitor | 0.124 0.017 CID_65036 | CID_65036 | |
| 0.029 | 0.042 | 0.097 | Cathepsin L1 inhibitor | 0.097 0.01 CID_65036 | CID_65036 | |
| 0.029 | 0.044 | 0.163 | Toll-Like receptor 2 agonist | 0.163 0.01 CID_154699921 | CID_154699921 | |
| 0.133 | 0.15 | 0.152 | Neurotensin receptor agonist | 0.152 0.097 CID_154699921 | CID_154699921 | |
| 0.022 | 0.049 | 0.148 | Integrin antagonist | 0.148 0.01 CID_154699921 | CID_154699921 | |
| 0.02 | 0.051 | 0.029 | Calcitonin receptor agonist | 0.029 0.028 CID_154699921 | CID_154699921 | |
| 0.017 | 0.05 | 0.047 | Arginase inhibitor | 0.047 0.017 CID_154699921 | CID_154699921 | |
| 0.007 | 0.058 | 0.025 | Neutral endopeptidase inhibitor | 0.025 0.013 CID_154699921 | CID_154699921 | |
| 0.023 | 0.075 | 0.044 | Growth hormone release inhibitor | 0.044 0.027 CID_154699921 | CID_154699921 | |
| 0.094 | 0.159 | 0.142 | Phospholipase A2 inhibitor | 0.142 0.083 CID_154699921 | CID_154699921 | |
| 0.004 | 0.079 | 0.014 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.014 0.011 CID_154699921 | CID_154699921 | |
| 0.019 | 0.106 | 0.063 | Erythropoietin receptor agonist | 0.063 0.016 CID_154699921 | CID_154699921 | |
| 0.026 | 0.132 | 0.038 | Integrin alpha1beta1 antagonist | 0.038 0.028 CID_154699921 | CID_154699921 | |
| 0.047 | 0.162 | 0.095 | Protein-tyrosine phosphatase 1B inhibitor | 0.095 0.084 CID_154699921 | CID_154699921 | |
| 0.015 | 0.14 | 0.049 | Glycine transporter 2 inhibitor | 0.049 0.031 CID_154699921 | CID_154699921 | |
| 0.062 | 0.242 | 0.137 | Folate antagonist | 0.137 0.028 CID_154699921 | CID_154699921 | |
| 0.034 | 0.272 | 0.073 | Chymotrypsin inhibitor | 0.073 0.066 CID_154699921 | CID_154699921 | |
| 0.043 | 0.281 | 0.202 | Sodium channel blocker | 0.202 0.031 CID_65036 | CID_65036 | |
| 0.139 | 0.381 | 0.972 | Cyclophilin D inhibitor | 0.972 0.004 CID_65036 | CID_65036 | |
| 0.048 | 0.301 | 0.368 | Angiogenesis stimulant | 0.368 0.028 CID_154699921 | CID_154699921 | |
| 0.053 | 0.371 | 0.994 | Platelet aggregation inhibitor | 0.994 0.001 CID_65036 | CID_65036 | |
| 0.025 | 0.401 | 0.129 | Protein-tyrosine phosphatase inhibitor | 0.129 0.103 CID_154699921 | CID_154699921 | |
| 0.016 | 0.393 | 0.087 | Sirtuin 1 inhibitor | 0.087 0.03 CID_154699921 | CID_154699921 | |
| 0.019 | 0.463 | 0.118 | Aminoacyl-tRNA synthetase inhibitor | 0.118 0.031 CID_154699921 | CID_154699921 | |
| 0.002 | 0.454 | 0.022 | Aminopeptidase P inhibitor | 0.022 0.018 CID_154699921 | CID_154699921 | |
| 0.012 | 0.487 | 0.039 | Neurokinin 2 agonist | 0.039 0.032 CID_154699921 | CID_154699921 | |
| 0.006 | 0.543 | 0.042 | Endothelin-converting enzyme inhibitor | 0.042 0.037 CID_154699921 | CID_154699921 | |
| 0.005 | 0.557 | 0.085 | Selectin antagonist | 0.085 0.034 CID_154699921 | CID_154699921 | |
| 0.003 | 0.561 | 0.058 | GP IIb/IIIa receptor antagonist | 0.058 0.029 CID_154699921 | CID_154699921 | |
| 0.004 | 0.583 | 0.047 | Collagenase inhibitor | 0.047 0.04 CID_154699921 | CID_154699921 | |
| 0.007 | 0.653 | 0.039 | VCAM-1 antagonist | 0.039 0.028 CID_154699921 | CID_154699921 | |
| 0.007 | 0.655 | 0.039 | VCAM antagonist | 0.039 0.028 CID_154699921 | CID_154699921 | |
| 0.005 | 0.678 | 0.044 | Integrin alpha5beta1 antagonist | 0.044 0.024 CID_154699921 | CID_154699921 | |
| 0.014 | 0.701 | 0.389 | Interleukin antagonist | 0.389 0.032 CID_154699921 | CID_154699921 | |
| 0.012 | 0.704 | 0.097 | Factor XII inhibitor | 0.097 0.041 CID_154699921 | CID_154699921 | |
| 0.003 | 0.696 | 0.084 | Leukotriene A4 hydrolase inhibitor | 0.084 0.008 CID_154699921 | CID_154699921 | |
| 0.004 | 0.702 | 0.031 | Bradykinin B2 receptor agonist | 0.031 0.017 CID_154699921 | CID_154699921 | |
| 0.009 | 0.719 | 0.042 | Cathepsin F inhibitor | 0.042 0.027 CID_154699921 | CID_154699921 | |
| 0.008 | 0.755 | 0.122 | Protease inhibitor | 0.122 0.046 CID_154699921 | CID_154699921 | |
| 0.008 | 0.764 | 0.041 | Cholecystokinin B agonist | 0.041 0.022 CID_154699921 | CID_154699921 | |
| 0.009 | 0.825 | 0.054 | Bombesin 1 receptor agonist | 0.054 0.049 CID_154699921 | CID_154699921 | |
| 0.013 | 0.859 | 0.076 | Adenine nucleotide translocase inhibitor | 0.076 0.011 CID_154699921 | CID_154699921 | |
| 0.009 | 0.915 | 0.171 | Histone deacetylase SIRT1 inhibitor | 0.171 0.045 CID_154699921 | CID_154699921 | |
| 0.021 | 0.932 | 0.401 | Sodium/bile acid cotransporter inhibitor | 0.401 0.016 CID_154699921 | CID_154699921 | |
| 0.013 | 0.937 | 0.215 | Hematopoietic | 0.215 0.009 CID_154699921 | CID_154699921 | |
| 0.02 | 0.961 | 0.141 | Factor V inhibitor | 0.141 0.023 CID_154699921 | CID_154699921 | |
| 0.026 | 0.977 | 0.314 | Interleukin 2 agonist | 0.314 0.064 CID_154699921 | CID_154699921 | |
| 0.003 | 0.98 | 0.087 | Glucagon-like peptide 1 agonist | 0.087 0.03 CID_154699921 | CID_154699921 | |
| 0.003 | 0.989 | 0.915 | Platelet activating factor antagonist | 0.915 0.003 CID_65036 | CID_65036 | |
| 0.006 | 0.994 | 0.07 | Caspase 9 inhibitor | 0.07 0.032 CID_154699921 | CID_154699921 | |
| 0.003 | 0.992 | 0.043 | Neurotensin receptor antagonist | 0.043 0.034 CID_154699921 | CID_154699921 | |
| 0.003 | 0.996 | 0.04 | Glutamate (mGluR8) antagonist | 0.04 0.017 CID_154699921 | CID_154699921 | |
| 0.001 | 0.996 | 0.028 | Protocollagen prolyl hydroxylase inhibitor | 0.028 0.018 CID_154699921 | CID_154699921 | |
| 0.002 | 0.998 | 0.052 | Carbonic anhydrase II stimulant | 0.052 0.036 CID_154699921 | CID_154699921 | |
| 0.001 | 0.997 | 0.047 | Complement C3a chemotactic receptor antagonist | 0.047 0.028 CID_154699921 | CID_154699921 | |
| 0.001 | 0.997 | 0.039 | Carbonic anhydrase I stimulant | 0.039 0.024 CID_154699921 | CID_154699921 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |